ArticleGene therapy2004

Picolinic acid- or desferrioxamine-inducible autocrine activation of macrophages engineered to produce IFNgamma: an approach for gene therapy.

S Pastorino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.